Diet, exercise & lifestyle × glycemic control

TrialThe American journal of the medical sciences2011

The effect of gemfibrozil, niacin and cholestyramine combination therapy on metabolic syndrome in the Armed Forces Regression Study.

Richard A Krasuski et al.PubMed ↗Publisher ↗

What the trial testedas reported · 2011

No range given

Reported lower glycemic control, no range given

−1.10

As reported

difference −1.10, no interval

No range given

Reported lower glycemic control, no range given

−30.0percentage points

As reported

difference −30.0 %, no interval

+2 more in the walkthrough ↓

Four numbers in the abstract

the abstract, start to end

decreased from 2.2 ± 0.9 to 1.9 ± 1.1 (P = 0.01), and prevalence of metabolic syndrome decreased from 44% to 30% (P = 0.15).

components decreased from 2.2 ± 0.9 to 1.0 ± 1.0 (P < 0.001), and prevalence of metabolic syndrome decreased from 32% to 6% (P < 0.001).

← favours treatmentfavours comparator →
could be chance
No interval given · direction only, strength unknown
Glycemic control
−1.10
Glycemic control
−30.0
Glycemic control
−1.00
Glycemic control
−6.00
Diet, exercise & lifestyleGlycemic control

Diet, exercise & lifestyle × glycemic controlhelps?replicated

unlikelylikely
0.990.99 without it
← favours treatmentfavours comparator →
this papermore certainless certain
1 / 6

2 papers cite it

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 21358314